{"id":354134,"date":"2025-08-28T10:56:36","date_gmt":"2025-08-28T10:56:36","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-apogee-therapeutics\/"},"modified":"2025-08-28T10:56:36","modified_gmt":"2025-08-28T10:56:36","slug":"how-to-buy-apogee-therapeutics","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-apogee-therapeutics\/","title":{"rendered":"Apogee Therapeutics, Inc. (APGE) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Apogee Therapeutics, Inc. (APGE) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334045,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-354134","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Apogee Therapeutics, Inc. (APGE) Hisseleri Nas\u0131l Al\u0131n\u0131r - APGE Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Apogee Therapeutics, Inc. (APGE) Hisseleri Nas\u0131l Al\u0131n\u0131r - APGE Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Kapsaml\u0131 yat\u0131r\u0131m rehberimizle Apogee Therapeutics (APGE) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 \u00f6\u011frenin. Bu umut vadeden biyoteknoloji \u015firketi i\u00e7in g\u00fcncel hisse fiyat\u0131n\u0131, riskleri ve b\u00fcy\u00fcme potansiyelini ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Kapsaml\u0131 yat\u0131r\u0131m rehberimizle Apogee Therapeutics (APGE) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 \u00f6\u011frenin. Bu umut vadeden biyoteknoloji \u015firketi i\u00e7in g\u00fcncel hisse fiyat\u0131n\u0131, riskleri ve b\u00fcy\u00fcme potansiyelini ke\u015ffedin."},"intro":"T\u0131pta bir sonraki \u00e7\u0131\u011f\u0131r a\u00e7an geli\u015fmenin bir par\u00e7as\u0131na sahip oldu\u011funuzu hayal edin. Apogee Therapeutics, milyonlarca hayat\u0131 d\u00f6n\u00fc\u015ft\u00fcrebilecek tedavilerle biyoteknoloji inovasyonunun \u00f6n saflar\u0131nda yer al\u0131yor. Bu sadece yat\u0131r\u0131m yapmak de\u011fil\u2014ayn\u0131 zamanda t\u0131bb\u0131n gelece\u011fini desteklemek ve servetinizi potansiyel olarak b\u00fcy\u00fctmekle ilgilidir.","intro_source":{"label":"Intro","type":"text","formatted_value":"T\u0131pta bir sonraki \u00e7\u0131\u011f\u0131r a\u00e7an geli\u015fmenin bir par\u00e7as\u0131na sahip oldu\u011funuzu hayal edin. Apogee Therapeutics, milyonlarca hayat\u0131 d\u00f6n\u00fc\u015ft\u00fcrebilecek tedavilerle biyoteknoloji inovasyonunun \u00f6n saflar\u0131nda yer al\u0131yor. Bu sadece yat\u0131r\u0131m yapmak de\u011fil\u2014ayn\u0131 zamanda t\u0131bb\u0131n gelece\u011fini desteklemek ve servetinizi potansiyel olarak b\u00fcy\u00fctmekle ilgilidir."},"body_html":"<h2>\ud83d\udcc8 APGE Hisse Senedi: G\u00fcncel Fiyat ve \u00d6nemli Tarihler<\/h2> <p>28 A\u011fustos 2025 itibar\u0131yla Apogee Therapeutics (APGE) hisseleri <strong>36,94 $<\/strong> fiyatla i\u015flem g\u00f6r\u00fcyor. Takviminize <strong>11 Kas\u0131m 2025<\/strong> tarihini not edin\u2014\u015firketin bir sonraki \u00e7eyrek kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 g\u00fcn. Tarihsel olarak, bu a\u00e7\u0131klamalar deneyimli yat\u0131r\u0131mc\u0131lar\u0131n yararlanabilece\u011fi \u00f6nemli fiyat hareketleri yaratm\u0131\u015ft\u0131r.<\/p> <p><strong>Kazan\u00e7 Raporlar\u0131n\u0131n APGE Hisse Senedine Etkisi<\/strong><\/p> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Haber \u00d6ncesi Fiyat<\/th><th>Haber Sonras\u0131 De\u011fi\u015fim<\/th><\/tr> <\/thead> <tbody> <tr><td>11 A\u011fu 2025<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>38,50 $<\/td><td>%4,1 D\u00fc\u015f\u00fc\u015f (EPS hedefi ka\u00e7\u0131r\u0131ld\u0131)<\/td><\/tr> <tr><td>12 May 2025<\/td><td>1. \u00c7eyrek Sonu\u00e7lar\u0131<\/td><td>35,20 $<\/td><td>%8,2 Art\u0131\u015f (pipeline ilerlemesi)<\/td><\/tr> <tr><td>10 \u015eub 2025<\/td><td>Y\u0131ll\u0131k Rapor<\/td><td>32,80 $<\/td><td>%6,5 Art\u0131\u015f (g\u00fc\u00e7l\u00fc nakit pozisyonu)<\/td><\/tr> <tr><td>12 Kas 2024<\/td><td>3. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>29,40 $<\/td><td>%11,9 Art\u0131\u015f (klinik g\u00fcncellemeler)<\/td><\/tr> <tr><td>13 A\u011fu 2024<\/td><td>2. \u00c7eyrek Sonu\u00e7lar\u0131<\/td><td>27,10 $<\/td><td>%8,1 Art\u0131\u015f (deneme kayd\u0131)<\/td><\/tr> <tr><td>14 May 2024<\/td><td>1. \u00c7eyrek Raporu<\/td><td>25,60 $<\/td><td>%5,9 Art\u0131\u015f (analist y\u00fckseltmeleri)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Trend Analizi<\/strong>: Pozitif klinik g\u00fcncellemeler genellikle %8-12 kazan\u00e7 sa\u011flarken, kazan\u00e7 hedeflerinin ka\u00e7\u0131r\u0131lmas\u0131 ge\u00e7ici %3-5 d\u00fc\u015f\u00fc\u015flere neden olur. Hisse senedi, g\u00fc\u00e7l\u00fc analist deste\u011fi sayesinde haftalar i\u00e7inde istikrarl\u0131 \u015fekilde toparlan\u0131r.<\/p>  [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Seyri ve Trend Analizi<\/h2> <p>Apogee hisseleri son alt\u0131 ayda <strong>%40,7 oynakl\u0131k<\/strong> ya\u015fad\u0131 ve 26,20 $ ile 63,50 $ aras\u0131nda i\u015flem g\u00f6rd\u00fc. \u0130\u015fte detayl\u0131 seyir:<\/p> <table> <thead> <tr><th>Ay<\/th><th>Fiyat Aral\u0131\u011f\u0131<\/th><th>\u00d6nemli Kataliz\u00f6r<\/th><\/tr> <\/thead> <tbody> <tr><td>Mart 2025<\/td><td>58-63 $<\/td><td>Faz 2 deneme beklentisi<\/td><\/tr> <tr><td>Nisan 2025<\/td><td>52-58 $<\/td><td>Piyasa d\u00fczeltmesi<\/td><\/tr> <tr><td>May\u0131s 2025<\/td><td>48-54 $<\/td><td>1. \u00c7eyrek kazan\u00e7lar\u0131 beklentiyi a\u015fmas\u0131<\/td><\/tr> <tr><td>Haziran 2025<\/td><td>42-48 $<\/td><td>Geni\u015f \u00e7apl\u0131 biyoteknoloji sat\u0131\u015flar\u0131<\/td><\/tr> <tr><td>Temmuz 2025<\/td><td>36-44 $<\/td><td>Olumlu APG777 sonu\u00e7lar\u0131<\/td><\/tr> <tr><td>A\u011fustos 2025<\/td><td>34-39 $<\/td><td>Kazan\u00e7 sonras\u0131 konsolidasyon<\/td><\/tr> <\/tbody> <\/table> <p>Hisse senedi \u015fu anda <strong>52 haftal\u0131k dip seviyesinin %29,7 \u00fczerinde<\/strong> ancak <strong>y\u0131ll\u0131k zirvesinin %41,8 alt\u0131nda<\/strong>. Bu, \u015firketin klinik pipeline'\u0131na inanan uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in cazip bir giri\u015f noktas\u0131 yarat\u0131yor.<\/p>  <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <ul> <li><strong>2025 Y\u0131l Sonu<\/strong>: 45-52 $ (4. \u00e7eyrek klinik g\u00fcncellemelerine dayanarak) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><\/li> <li><strong>2026 Hedefi<\/strong>: 75-90 $ (Faz 3 ba\u015flang\u0131\u00e7 kataliz\u00f6rleri)<\/li> <li><strong>2028 Projeksiyonu<\/strong>: 150-200 $ (muhtemel ilk onay)<\/li> <li><strong>2030 Vizyonu<\/strong>: 300-400 $ (birden fazla ticari \u00fcr\u00fcn)<\/li> <\/ul> <p>Analistler oybirli\u011fiyle <a href=\"https:\/\/stockanalysis.com\/stocks\/apge\/forecast\/\">\"G\u00fc\u00e7l\u00fc Al\" notu ve ortalama 97,50 $ hedef fiyat<\/a> veriyor, bu da <strong>%164 y\u00fckseli\u015f potansiyeli<\/strong> anlam\u0131na geliyor. En iyimser projeksiyonlar, klinik denemeler ba\u015far\u0131l\u0131 olursa APGE'nin 2030'a kadar 400 $+ seviyesine ula\u015fabilece\u011fini g\u00f6steriyor.<\/p>  <h2>\u26a0\ufe0f Temel Riskler ve Pozitif \u0130\u015faretler<\/h2> <p><strong>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/strong><\/p> <ul> <li>Klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131 de\u011ferin %50-80'ini silebilir<\/li> <li>Y\u0131ll\u0131k 238 milyon $ y\u00fcksek nakit t\u00fcketimi ve gelir olmamas\u0131<\/li> <li>Yerle\u015fik oyuncular\u0131n bulundu\u011fu rekabet\u00e7i atopik dermatit pazar\u0131<\/li> <li>Faz 3 denemelerinde d\u00fczenleyici engeller<\/li> <li>Piyasa kar\u015f\u0131s\u0131nda 1,44 beta ile hisse oynakl\u0131\u011f\u0131<\/li> <\/ul> <p><strong>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/strong><\/p> <ul> <li><a href=\"https:\/\/www.stocktitan.net\/news\/APGE\/apogee-therapeutics-provides-pipeline-progress-and-reports-second-ehgz90qj9xb6.html\">Faz 2 APG777 atopik dermatitte %71 etkinlik g\u00f6sterdi<\/a><\/li> <li>2028'e kadar 621 milyon $ nakit rezervi (bor\u00e7suz)<\/li> <li>Her analist APGE i\u00e7in G\u00fc\u00e7l\u00fc Al notu veriyor<\/li> <li>Klinik zaman \u00e7izelgesi 2026 ortas\u0131na h\u0131zland\u0131r\u0131ld\u0131<\/li> <li>B\u00fcy\u00fck adreslenebilir pazarlar (5 milyar $+ potansiyel)<\/li> <\/ul>  <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir Yat\u0131r\u0131mc\u0131 Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong> - Portf\u00f6y\u00fcn\u00fcz\u00fcn sadece %2-5'ini y\u00fcksek riskli biyoteknolojiye ay\u0131r\u0131n<\/li> <li><strong>Dolar maliyeti ortalamas\u0131 yap\u0131n<\/strong> - Kazan\u00e7 tarihleri civar\u0131nda par\u00e7a par\u00e7a al\u0131m yap\u0131n<\/li> <li><strong>Stop-loss seviyeleri belirleyin<\/strong> - Giri\u015f fiyat\u0131n\u0131n %25 alt\u0131na stop-loss koyarak riski y\u00f6netin<\/li> <li><strong>11 Kas\u0131m kazan\u00e7lar\u0131n\u0131 takip edin<\/strong> - Potansiyel giri\u015f noktas\u0131 i\u00e7in<\/li> <\/ol> <p>Espiri: \"APGE ticareti t\u0131p fak\u00fcltesinde fl\u00f6rt etmek gibidir\u2014sonu\u00e7lar gelene kadar potansiyel dolu. Ama i\u015fe yararsa, doktorla evlenirsiniz!\"<\/p>  <h2>\u2705 Apogee Therapeutics, Inc. (APGE) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir ticaret platformu se\u00e7in<\/td><td>NASDAQ listeleri ve biyoteknoloji hisseleri sunmas\u0131na dikkat edin<\/td><\/tr> <tr><td>2<\/td><td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td><td>\u00c7o\u011fu platform kimlik ve adres kan\u0131t\u0131 ister<\/td><\/tr> <tr><td>3<\/td><td>Fon yat\u0131r\u0131n<\/td><td>Risk edebilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>4<\/td><td>\"APGE\" aramas\u0131 yap\u0131n<\/td><td>Sadece \u015firket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>Sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in<\/td><td>Giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td><\/tr> <tr><td>6<\/td><td>Sipari\u015f detaylar\u0131n\u0131 g\u00f6zden ge\u00e7irin<\/td><td>Komisyon \u00fccretleri ve takas s\u00fcresini kontrol edin<\/td><\/tr> <tr><td>7<\/td><td>Al\u0131m\u0131 ger\u00e7ekle\u015ftirin<\/td><td>Hisse say\u0131s\u0131 ve toplam maliyeti onaylay\u0131n<\/td><\/tr> <tr><td>8<\/td><td>Fiyat uyar\u0131lar\u0131 kurun<\/td><td>Kazan\u00e7 ve klinik g\u00fcncellemeleri takip edin<\/td><\/tr> <tr><td>9<\/td><td>Yat\u0131r\u0131m tezini belgeleyin<\/td><td>Gelecek referanslar i\u00e7in neden ald\u0131\u011f\u0131n\u0131z\u0131 not edin<\/td><\/tr> <tr><td>10<\/td><td>\u00c7\u0131k\u0131\u015f stratejisi planlay\u0131n<\/td><td>K\u00e2r hedefleri ve stop-loss seviyelerini belirleyin<\/td><\/tr> <\/tbody> <\/table>  <h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2> <p>Yat\u0131r\u0131m yolculu\u011funa ba\u015flayanlar i\u00e7in Pocket Option ola\u011fan\u00fcst\u00fc eri\u015filebilirlik sunar:<\/p> <ul> <li><strong>Sadece 5 $ minimum depozito<\/strong> ile stratejileri d\u00fc\u015f\u00fck riskle test edin<\/li> <li><strong>1 dakikal\u0131k KYC s\u00fcreci<\/strong> ile herhangi bir resmi kimlik kullanarak hemen i\u015flem yapmaya ba\u015flay\u0131n<\/li> <li><strong>100+ para \u00e7ekme y\u00f6ntemi<\/strong> aras\u0131nda kripto paralar, e-c\u00fczdanlar ve banka transferleri bulunur<\/li> <li><strong>Kesirli hisse senedi al\u0131m\u0131<\/strong> ile APGE gibi pahal\u0131 hisselere k\u00fc\u00e7\u00fck miktarlarla yat\u0131r\u0131m yapabilirsiniz<\/li> <\/ul> <p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc biyoteknoloji yat\u0131r\u0131mlar\u0131n\u0131 kolayla\u015ft\u0131r\u0131rken, <a href=\"\/blog\">Pocket Option blog<\/a> \u00fczerindeki e\u011fitim kaynaklar\u0131 yeni ba\u015flayanlar\u0131n karma\u015f\u0131k t\u0131bbi terimleri ve klinik deneme a\u015famalar\u0131n\u0131 anlamalar\u0131na yard\u0131mc\u0131 olur.<\/p>  <h2>\ud83c\udf0d 2025'te Apogee Therapeutics: Biyoteknolojinin Y\u00fckselen Y\u0131ld\u0131z\u0131<\/h2> <p>Apogee Therapeutics, inflamatuar hastal\u0131klar i\u00e7in en iyi s\u0131n\u0131f tedaviler geli\u015ftirmeye odaklanan imm\u00fcnolojik ila\u00e7 geli\u015ftirme alan\u0131nda \u00f6nc\u00fc konumdad\u0131r. \u015eirketin yenilik\u00e7i yakla\u015f\u0131m\u0131, imm\u00fcnolojide yerle\u015fik mekanizmalar\u0131 hedef alan geli\u015fmi\u015f antikor m\u00fchendisli\u011fi kullanarak mevcut se\u00e7eneklere k\u0131yasla birinci s\u0131n\u0131f veya \u00fcst\u00fcn tedaviler sunma potansiyeline sahiptir.<\/p> <p>Mevcut pipeline hedefleri \u015funlard\u0131r:<\/p> <ul> <li><strong>Atopik dermatit<\/strong> (Faz 2, APG777 ile)<\/li> <li><strong>Ast\u0131m<\/strong> (Faz 1b, APG808 ile)<\/li> <li><strong>Eozinofilik \u00f6zofajit<\/strong> (Faz 1, APG777 ile)<\/li> <li><strong>Kronik Obstr\u00fcktif Akci\u011fer Hastal\u0131\u011f\u0131 (KOAH)<\/strong> (Preklinik, APG990 ile)<\/li> <\/ul> <p>\u015eirket, bor\u00e7suz 621 milyon $ nakit pozisyonunu koruyarak finansal istikrar\u0131n\u0131 bir\u00e7ok klinik d\u00f6n\u00fcm noktas\u0131na kadar sa\u011flamaktad\u0131r. Hisseyi takip eden sekiz analistin tamam\u0131 G\u00fc\u00e7l\u00fc Al notu verirken, kurumsal g\u00fcven son derece y\u00fcksektir.<\/p> <h3>\u0130lgin\u00e7 Bilgi:<\/h3> <p>2025 y\u0131l\u0131nda Apogee ara\u015ft\u0131rma ekibi, lider ila\u00e7 aday\u0131 APG777'nin sadece atopik dermatiti tedavi etmekle kalmay\u0131p ayn\u0131 zamanda mevsimsel alerji semptomlar\u0131n\u0131 azaltmada beklenmedik faydalar g\u00f6sterdi\u011fini ke\u015ffetti\u2014bu bulgu, pazar potansiyelini milyarlarca dolar art\u0131rabilir.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 APGE Hisse Senedi: G\u00fcncel Fiyat ve \u00d6nemli Tarihler<\/h2>\n<p>28 A\u011fustos 2025 itibar\u0131yla Apogee Therapeutics (APGE) hisseleri <strong>36,94 $<\/strong> fiyatla i\u015flem g\u00f6r\u00fcyor. Takviminize <strong>11 Kas\u0131m 2025<\/strong> tarihini not edin\u2014\u015firketin bir sonraki \u00e7eyrek kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 g\u00fcn. Tarihsel olarak, bu a\u00e7\u0131klamalar deneyimli yat\u0131r\u0131mc\u0131lar\u0131n yararlanabilece\u011fi \u00f6nemli fiyat hareketleri yaratm\u0131\u015ft\u0131r.<\/p>\n<p><strong>Kazan\u00e7 Raporlar\u0131n\u0131n APGE Hisse Senedine Etkisi<\/strong><\/p>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>11 A\u011fu 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>38,50 $<\/td>\n<td>%4,1 D\u00fc\u015f\u00fc\u015f (EPS hedefi ka\u00e7\u0131r\u0131ld\u0131)<\/td>\n<\/tr>\n<tr>\n<td>12 May 2025<\/td>\n<td>1. \u00c7eyrek Sonu\u00e7lar\u0131<\/td>\n<td>35,20 $<\/td>\n<td>%8,2 Art\u0131\u015f (pipeline ilerlemesi)<\/td>\n<\/tr>\n<tr>\n<td>10 \u015eub 2025<\/td>\n<td>Y\u0131ll\u0131k Rapor<\/td>\n<td>32,80 $<\/td>\n<td>%6,5 Art\u0131\u015f (g\u00fc\u00e7l\u00fc nakit pozisyonu)<\/td>\n<\/tr>\n<tr>\n<td>12 Kas 2024<\/td>\n<td>3. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>29,40 $<\/td>\n<td>%11,9 Art\u0131\u015f (klinik g\u00fcncellemeler)<\/td>\n<\/tr>\n<tr>\n<td>13 A\u011fu 2024<\/td>\n<td>2. \u00c7eyrek Sonu\u00e7lar\u0131<\/td>\n<td>27,10 $<\/td>\n<td>%8,1 Art\u0131\u015f (deneme kayd\u0131)<\/td>\n<\/tr>\n<tr>\n<td>14 May 2024<\/td>\n<td>1. \u00c7eyrek Raporu<\/td>\n<td>25,60 $<\/td>\n<td>%5,9 Art\u0131\u015f (analist y\u00fckseltmeleri)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Trend Analizi<\/strong>: Pozitif klinik g\u00fcncellemeler genellikle %8-12 kazan\u00e7 sa\u011flarken, kazan\u00e7 hedeflerinin ka\u00e7\u0131r\u0131lmas\u0131 ge\u00e7ici %3-5 d\u00fc\u015f\u00fc\u015flere neden olur. Hisse senedi, g\u00fc\u00e7l\u00fc analist deste\u011fi sayesinde haftalar i\u00e7inde istikrarl\u0131 \u015fekilde toparlan\u0131r.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Seyri ve Trend Analizi<\/h2>\n<p>Apogee hisseleri son alt\u0131 ayda <strong>%40,7 oynakl\u0131k<\/strong> ya\u015fad\u0131 ve 26,20 $ ile 63,50 $ aras\u0131nda i\u015flem g\u00f6rd\u00fc. \u0130\u015fte detayl\u0131 seyir:<\/p>\n<table>\n<thead>\n<tr>\n<th>Ay<\/th>\n<th>Fiyat Aral\u0131\u011f\u0131<\/th>\n<th>\u00d6nemli Kataliz\u00f6r<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Mart 2025<\/td>\n<td>58-63 $<\/td>\n<td>Faz 2 deneme beklentisi<\/td>\n<\/tr>\n<tr>\n<td>Nisan 2025<\/td>\n<td>52-58 $<\/td>\n<td>Piyasa d\u00fczeltmesi<\/td>\n<\/tr>\n<tr>\n<td>May\u0131s 2025<\/td>\n<td>48-54 $<\/td>\n<td>1. \u00c7eyrek kazan\u00e7lar\u0131 beklentiyi a\u015fmas\u0131<\/td>\n<\/tr>\n<tr>\n<td>Haziran 2025<\/td>\n<td>42-48 $<\/td>\n<td>Geni\u015f \u00e7apl\u0131 biyoteknoloji sat\u0131\u015flar\u0131<\/td>\n<\/tr>\n<tr>\n<td>Temmuz 2025<\/td>\n<td>36-44 $<\/td>\n<td>Olumlu APG777 sonu\u00e7lar\u0131<\/td>\n<\/tr>\n<tr>\n<td>A\u011fustos 2025<\/td>\n<td>34-39 $<\/td>\n<td>Kazan\u00e7 sonras\u0131 konsolidasyon<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Hisse senedi \u015fu anda <strong>52 haftal\u0131k dip seviyesinin %29,7 \u00fczerinde<\/strong> ancak <strong>y\u0131ll\u0131k zirvesinin %41,8 alt\u0131nda<\/strong>. Bu, \u015firketin klinik pipeline&#8217;\u0131na inanan uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in cazip bir giri\u015f noktas\u0131 yarat\u0131yor.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<ul>\n<li><strong>2025 Y\u0131l Sonu<\/strong>: 45-52 $ (4. \u00e7eyrek klinik g\u00fcncellemelerine dayanarak) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><\/li>\n<li><strong>2026 Hedefi<\/strong>: 75-90 $ (Faz 3 ba\u015flang\u0131\u00e7 kataliz\u00f6rleri)<\/li>\n<li><strong>2028 Projeksiyonu<\/strong>: 150-200 $ (muhtemel ilk onay)<\/li>\n<li><strong>2030 Vizyonu<\/strong>: 300-400 $ (birden fazla ticari \u00fcr\u00fcn)<\/li>\n<\/ul>\n<p>Analistler oybirli\u011fiyle <a href=\"https:\/\/stockanalysis.com\/stocks\/apge\/forecast\/\">&#8220;G\u00fc\u00e7l\u00fc Al&#8221; notu ve ortalama 97,50 $ hedef fiyat<\/a> veriyor, bu da <strong>%164 y\u00fckseli\u015f potansiyeli<\/strong> anlam\u0131na geliyor. En iyimser projeksiyonlar, klinik denemeler ba\u015far\u0131l\u0131 olursa APGE&#8217;nin 2030&#8217;a kadar 400 $+ seviyesine ula\u015fabilece\u011fini g\u00f6steriyor.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Pozitif \u0130\u015faretler<\/h2>\n<p><strong>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/strong><\/p>\n<ul>\n<li>Klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131 de\u011ferin %50-80&#8217;ini silebilir<\/li>\n<li>Y\u0131ll\u0131k 238 milyon $ y\u00fcksek nakit t\u00fcketimi ve gelir olmamas\u0131<\/li>\n<li>Yerle\u015fik oyuncular\u0131n bulundu\u011fu rekabet\u00e7i atopik dermatit pazar\u0131<\/li>\n<li>Faz 3 denemelerinde d\u00fczenleyici engeller<\/li>\n<li>Piyasa kar\u015f\u0131s\u0131nda 1,44 beta ile hisse oynakl\u0131\u011f\u0131<\/li>\n<\/ul>\n<p><strong>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/strong><\/p>\n<ul>\n<li><a href=\"https:\/\/www.stocktitan.net\/news\/APGE\/apogee-therapeutics-provides-pipeline-progress-and-reports-second-ehgz90qj9xb6.html\">Faz 2 APG777 atopik dermatitte %71 etkinlik g\u00f6sterdi<\/a><\/li>\n<li>2028&#8217;e kadar 621 milyon $ nakit rezervi (bor\u00e7suz)<\/li>\n<li>Her analist APGE i\u00e7in G\u00fc\u00e7l\u00fc Al notu veriyor<\/li>\n<li>Klinik zaman \u00e7izelgesi 2026 ortas\u0131na h\u0131zland\u0131r\u0131ld\u0131<\/li>\n<li>B\u00fcy\u00fck adreslenebilir pazarlar (5 milyar $+ potansiyel)<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir Yat\u0131r\u0131mc\u0131 Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong> &#8211; Portf\u00f6y\u00fcn\u00fcz\u00fcn sadece %2-5&#8217;ini y\u00fcksek riskli biyoteknolojiye ay\u0131r\u0131n<\/li>\n<li><strong>Dolar maliyeti ortalamas\u0131 yap\u0131n<\/strong> &#8211; Kazan\u00e7 tarihleri civar\u0131nda par\u00e7a par\u00e7a al\u0131m yap\u0131n<\/li>\n<li><strong>Stop-loss seviyeleri belirleyin<\/strong> &#8211; Giri\u015f fiyat\u0131n\u0131n %25 alt\u0131na stop-loss koyarak riski y\u00f6netin<\/li>\n<li><strong>11 Kas\u0131m kazan\u00e7lar\u0131n\u0131 takip edin<\/strong> &#8211; Potansiyel giri\u015f noktas\u0131 i\u00e7in<\/li>\n<\/ol>\n<p>Espiri: &#8220;APGE ticareti t\u0131p fak\u00fcltesinde fl\u00f6rt etmek gibidir\u2014sonu\u00e7lar gelene kadar potansiyel dolu. Ama i\u015fe yararsa, doktorla evlenirsiniz!&#8221;<\/p>\n<h2>\u2705 Apogee Therapeutics, Inc. (APGE) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir ticaret platformu se\u00e7in<\/td>\n<td>NASDAQ listeleri ve biyoteknoloji hisseleri sunmas\u0131na dikkat edin<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>\u00c7o\u011fu platform kimlik ve adres kan\u0131t\u0131 ister<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Fon yat\u0131r\u0131n<\/td>\n<td>Risk edebilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>&#8220;APGE&#8221; aramas\u0131 yap\u0131n<\/td>\n<td>Sadece \u015firket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in<\/td>\n<td>Giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Sipari\u015f detaylar\u0131n\u0131 g\u00f6zden ge\u00e7irin<\/td>\n<td>Komisyon \u00fccretleri ve takas s\u00fcresini kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Al\u0131m\u0131 ger\u00e7ekle\u015ftirin<\/td>\n<td>Hisse say\u0131s\u0131 ve toplam maliyeti onaylay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Fiyat uyar\u0131lar\u0131 kurun<\/td>\n<td>Kazan\u00e7 ve klinik g\u00fcncellemeleri takip edin<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>Yat\u0131r\u0131m tezini belgeleyin<\/td>\n<td>Gelecek referanslar i\u00e7in neden ald\u0131\u011f\u0131n\u0131z\u0131 not edin<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>\u00c7\u0131k\u0131\u015f stratejisi planlay\u0131n<\/td>\n<td>K\u00e2r hedefleri ve stop-loss seviyelerini belirleyin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2>\n<p>Yat\u0131r\u0131m yolculu\u011funa ba\u015flayanlar i\u00e7in Pocket Option ola\u011fan\u00fcst\u00fc eri\u015filebilirlik sunar:<\/p>\n<ul>\n<li><strong>Sadece 5 $ minimum depozito<\/strong> ile stratejileri d\u00fc\u015f\u00fck riskle test edin<\/li>\n<li><strong>1 dakikal\u0131k KYC s\u00fcreci<\/strong> ile herhangi bir resmi kimlik kullanarak hemen i\u015flem yapmaya ba\u015flay\u0131n<\/li>\n<li><strong>100+ para \u00e7ekme y\u00f6ntemi<\/strong> aras\u0131nda kripto paralar, e-c\u00fczdanlar ve banka transferleri bulunur<\/li>\n<li><strong>Kesirli hisse senedi al\u0131m\u0131<\/strong> ile APGE gibi pahal\u0131 hisselere k\u00fc\u00e7\u00fck miktarlarla yat\u0131r\u0131m yapabilirsiniz<\/li>\n<\/ul>\n<p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc biyoteknoloji yat\u0131r\u0131mlar\u0131n\u0131 kolayla\u015ft\u0131r\u0131rken, <a href=\"\/blog\">Pocket Option blog<\/a> \u00fczerindeki e\u011fitim kaynaklar\u0131 yeni ba\u015flayanlar\u0131n karma\u015f\u0131k t\u0131bbi terimleri ve klinik deneme a\u015famalar\u0131n\u0131 anlamalar\u0131na yard\u0131mc\u0131 olur.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te Apogee Therapeutics: Biyoteknolojinin Y\u00fckselen Y\u0131ld\u0131z\u0131<\/h2>\n<p>Apogee Therapeutics, inflamatuar hastal\u0131klar i\u00e7in en iyi s\u0131n\u0131f tedaviler geli\u015ftirmeye odaklanan imm\u00fcnolojik ila\u00e7 geli\u015ftirme alan\u0131nda \u00f6nc\u00fc konumdad\u0131r. \u015eirketin yenilik\u00e7i yakla\u015f\u0131m\u0131, imm\u00fcnolojide yerle\u015fik mekanizmalar\u0131 hedef alan geli\u015fmi\u015f antikor m\u00fchendisli\u011fi kullanarak mevcut se\u00e7eneklere k\u0131yasla birinci s\u0131n\u0131f veya \u00fcst\u00fcn tedaviler sunma potansiyeline sahiptir.<\/p>\n<p>Mevcut pipeline hedefleri \u015funlard\u0131r:<\/p>\n<ul>\n<li><strong>Atopik dermatit<\/strong> (Faz 2, APG777 ile)<\/li>\n<li><strong>Ast\u0131m<\/strong> (Faz 1b, APG808 ile)<\/li>\n<li><strong>Eozinofilik \u00f6zofajit<\/strong> (Faz 1, APG777 ile)<\/li>\n<li><strong>Kronik Obstr\u00fcktif Akci\u011fer Hastal\u0131\u011f\u0131 (KOAH)<\/strong> (Preklinik, APG990 ile)<\/li>\n<\/ul>\n<p>\u015eirket, bor\u00e7suz 621 milyon $ nakit pozisyonunu koruyarak finansal istikrar\u0131n\u0131 bir\u00e7ok klinik d\u00f6n\u00fcm noktas\u0131na kadar sa\u011flamaktad\u0131r. Hisseyi takip eden sekiz analistin tamam\u0131 G\u00fc\u00e7l\u00fc Al notu verirken, kurumsal g\u00fcven son derece y\u00fcksektir.<\/p>\n<h3>\u0130lgin\u00e7 Bilgi:<\/h3>\n<p>2025 y\u0131l\u0131nda Apogee ara\u015ft\u0131rma ekibi, lider ila\u00e7 aday\u0131 APG777&#8217;nin sadece atopik dermatiti tedavi etmekle kalmay\u0131p ayn\u0131 zamanda mevsimsel alerji semptomlar\u0131n\u0131 azaltmada beklenmedik faydalar g\u00f6sterdi\u011fini ke\u015ffetti\u2014bu bulgu, pazar potansiyelini milyarlarca dolar art\u0131rabilir.<\/p>\n"},"faq":[{"question":"Apogee Therapeutics hisseleri nereden al\u0131nabilir?","answer":"Apogee Therapeutics hisseleri NASDAQ borsas\u0131nda APGE sembol\u00fc ile i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden sat\u0131n alabilirsiniz."},{"question":"APGE hisseleri i\u00e7in riskler nelerdir?","answer":"Ba\u015fl\u0131ca riskler aras\u0131nda klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131, y\u00fcksek nakit t\u00fcketimi, rekabet\u00e7i pazar ko\u015fullar\u0131 ve d\u00fczenleyici engeller bulunmaktad\u0131r."},{"question":"APGE hisseleri i\u00e7in fiyat tahmini nedir?","answer":"Analistler 2025 sonunda 45-52 $, 2026'da 75-90 $, 2028'de 150-200 $ ve 2030'da 300-400 $ aral\u0131\u011f\u0131nda fiyatlar \u00f6ng\u00f6rmektedir."},{"question":"Yeni ba\u015flayanlar APGE hissesi al\u0131rken nelere dikkat etmeli?","answer":"K\u00fc\u00e7\u00fck yat\u0131r\u0131mlarla ba\u015flay\u0131n, dolar maliyeti ortalamas\u0131 yap\u0131n, stop-loss seviyeleri belirleyin ve \u00f6nemli kazan\u00e7 tarihlerini takip edin."},{"question":"Pocket Option APGE hissesi yat\u0131r\u0131m\u0131 i\u00e7in neden \u00f6nerilir?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 KYC s\u00fcreci, \u00e7ok say\u0131da para \u00e7ekme y\u00f6ntemi ve kesirli hisse al\u0131m imkan\u0131 sunmas\u0131 nedeniyle yeni yat\u0131r\u0131mc\u0131lar i\u00e7in uygundur."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Apogee Therapeutics hisseleri nereden al\u0131nabilir?","answer":"Apogee Therapeutics hisseleri NASDAQ borsas\u0131nda APGE sembol\u00fc ile i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden sat\u0131n alabilirsiniz."},{"question":"APGE hisseleri i\u00e7in riskler nelerdir?","answer":"Ba\u015fl\u0131ca riskler aras\u0131nda klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131, y\u00fcksek nakit t\u00fcketimi, rekabet\u00e7i pazar ko\u015fullar\u0131 ve d\u00fczenleyici engeller bulunmaktad\u0131r."},{"question":"APGE hisseleri i\u00e7in fiyat tahmini nedir?","answer":"Analistler 2025 sonunda 45-52 $, 2026'da 75-90 $, 2028'de 150-200 $ ve 2030'da 300-400 $ aral\u0131\u011f\u0131nda fiyatlar \u00f6ng\u00f6rmektedir."},{"question":"Yeni ba\u015flayanlar APGE hissesi al\u0131rken nelere dikkat etmeli?","answer":"K\u00fc\u00e7\u00fck yat\u0131r\u0131mlarla ba\u015flay\u0131n, dolar maliyeti ortalamas\u0131 yap\u0131n, stop-loss seviyeleri belirleyin ve \u00f6nemli kazan\u00e7 tarihlerini takip edin."},{"question":"Pocket Option APGE hissesi yat\u0131r\u0131m\u0131 i\u00e7in neden \u00f6nerilir?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 KYC s\u00fcreci, \u00e7ok say\u0131da para \u00e7ekme y\u00f6ntemi ve kesirli hisse al\u0131m imkan\u0131 sunmas\u0131 nedeniyle yeni yat\u0131r\u0131mc\u0131lar i\u00e7in uygundur."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Apogee Therapeutics, Inc. (APGE) Hisseleri Nas\u0131l Al\u0131n\u0131r - Apogee Therapeutics, Inc. (APGE) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-apogee-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Apogee Therapeutics, Inc. (APGE) Hisseleri Nas\u0131l Al\u0131n\u0131r - Apogee Therapeutics, Inc. (APGE) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-apogee-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-28T10:56:36+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-apogee-therapeutics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-apogee-therapeutics\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Apogee Therapeutics, Inc. (APGE) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Apogee Therapeutics, Inc. (APGE) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-28T10:56:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-apogee-therapeutics\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-apogee-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-apogee-therapeutics\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-apogee-therapeutics\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-apogee-therapeutics\/\",\"name\":\"Apogee Therapeutics, Inc. (APGE) Hisseleri Nas\u0131l Al\u0131n\u0131r - Apogee Therapeutics, Inc. (APGE) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-apogee-therapeutics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-apogee-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp\",\"datePublished\":\"2025-08-28T10:56:36+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-apogee-therapeutics\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-apogee-therapeutics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-apogee-therapeutics\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-apogee-therapeutics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Apogee Therapeutics, Inc. (APGE) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Apogee Therapeutics, Inc. (APGE) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Apogee Therapeutics, Inc. (APGE) Hisseleri Nas\u0131l Al\u0131n\u0131r - Apogee Therapeutics, Inc. (APGE) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-apogee-therapeutics\/","og_locale":"tr_TR","og_type":"article","og_title":"Apogee Therapeutics, Inc. (APGE) Hisseleri Nas\u0131l Al\u0131n\u0131r - Apogee Therapeutics, Inc. (APGE) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-apogee-therapeutics\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-28T10:56:36+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-apogee-therapeutics\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-apogee-therapeutics\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Apogee Therapeutics, Inc. (APGE) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Apogee Therapeutics, Inc. (APGE) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-28T10:56:36+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-apogee-therapeutics\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-apogee-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-apogee-therapeutics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-apogee-therapeutics\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-apogee-therapeutics\/","name":"Apogee Therapeutics, Inc. (APGE) Hisseleri Nas\u0131l Al\u0131n\u0131r - Apogee Therapeutics, Inc. (APGE) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-apogee-therapeutics\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-apogee-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp","datePublished":"2025-08-28T10:56:36+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-apogee-therapeutics\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-apogee-therapeutics\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-apogee-therapeutics\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-apogee-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Apogee Therapeutics, Inc. (APGE) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Apogee Therapeutics, Inc. (APGE) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":354135,"slug":"how-to-buy-apogee-therapeutics","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Apogee Therapeutics, Inc. (APGE) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Apogee Therapeutics, Inc. (APGE)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-apogee-therapeutics\/"},"pt_AA":{"locale":"pt_AA","id":354130,"slug":"how-to-buy-apogee-therapeutics","post_title":"Como comprar a\u00e7\u00f5es da Apogee Therapeutics, Inc. (APGE) - Investimento em a\u00e7\u00f5es da Apogee Therapeutics, Inc. (APGE)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-apogee-therapeutics\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/354134","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=354134"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/354134\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334045"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=354134"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=354134"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=354134"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}